Publication Cover
Assistive Technology
The Official Journal of RESNA
Volume 35, 2023 - Issue 3
644
Views
2
CrossRef citations to date
0
Altmetric
Articles

Amputee, clinician, and regulator perspectives on current and prospective upper extremity prosthetic technologies

, DPTORCID Icon, , PhDORCID Icon, , MDORCID Icon, , PhDORCID Icon & , PhDORCID Icon
Pages 258-270 | Accepted 14 Dec 2021, Published online: 19 Feb 2022
 

ABSTRACT

Existing prosthetic technologies for people with upper limb amputation are being adopted at moderate rates. Once fitted for these devices, many upper limb amputees report not using them regularly or at all. The primary aim of this study was to solicit feedback about prosthetic technology and important device design criteria from amputees, clinicians, and device regulators. We compare these perspectives to identify common or divergent priorities. Twenty-one adults with upper limb loss, 35 clinicians, and 3 regulators completed a survey on existing prosthetic technologies and a conceptual sensorimotor prosthesis driven by implanted myoelectric electrodes with sensory feedback via spinal root stimulation. The survey included questions from the Trinity Amputation and Prosthesis Experience Scale, the Disabilities of the Arm, Shoulder, and Hand, and novel questions about technology acceptance and neuroprosthetic design. User and clinician ratings of satisfaction with existing devices were similar. Amputees were most accepting of the proposed sensorimotor prosthesis (75.5% vs clinicians (68.8%), regulators (67.8%)). Stakeholders valued user-centered outcomes like individualized task goals, improved quality of life, device reliability, and user safety; regulators emphasized these last two. The results of this study provide insight into amputee, clinician, and regulator priorities to inform future upper-limb prosthetic design and clinical trial protocol development.

Acknowledgments

The authors would like thank Santiago Munoz for contributions to the survey design and Debbie Harrington for coordinating study activities and for assistance with data collection.

Disclosure statement

Robert Gaunt is on the scientific advisory board of Neurowired LLC.

Supplemental data

Supplemental data for this article can be accessed on the publisher’s website.

Additional information

Funding

Research was sponsored by the U.S. Army Research Office and the Defense Advanced Research Projects Agency (DARPA) was accomplished under Cooperative Agreement Number W911NF-15-2-0016. The views and conclusions contained in this document are those of the authors and should not be interpreted as representing the official policies, either expressed or implied, of the Army Research Office or the U.S. Government. The U.S. Government is authorized to reproduce and distribute reprints for Government purposes notwithstanding any copyright notation hereon.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 61.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 95.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.